Description
5-Amino-1MQ Research Compound | Selective NNMT Inhibitor for Metabolic, Muscle & Longevity Preclinical Studies

5-Amino-1MQ (NNMT inhibitor) research compound — in-depth guide to preclinical studies on NAD+ preservation, adipose tissue remodeling, muscle strength, mitochondrial function and metabolic longevity pathways. Strictly supplied for laboratory research use only.
What is 5-Amino-1MQ?
5-Amino-1MQ, chemically known as 5-amino-1-methylquinolinium, is a small-molecule quinolinium derivative developed as a potent and highly selective inhibitor of the enzyme Nicotinamide N-Methyltransferase (NNMT). Researchers are actively studying this compound in cell culture, tissue explants, and animal models because of its ability to modulate key metabolic regulators without requiring dietary intervention.
Detailed Mechanism of Action

In preclinical models, 5-Amino-1MQ inhibits NNMT → prevents excessive methylation of nicotinamide → preserves intracellular NAD+ pools → supports enhanced mitochondrial respiration and downstream metabolic signaling.
Comprehensive Research Focus Areas
[Insert Research Focus mind-map + new Highlights graphic here]
1. NNMT Inhibition & NAD+ Preservation Multiple independent laboratory studies have reported robust NNMT blockade and sustained NAD+ elevation in adipose, liver, and muscle tissues.
2. Adipose Tissue & Body Composition Models In diet-induced obesity rodent models, 5-Amino-1MQ treatment was associated with reduced adipocyte hypertrophy and favorable shifts in fat distribution.
3. Skeletal Muscle Strength & Regeneration Aged mouse studies showed improvements in grip strength, treadmill endurance, and markers of muscle regeneration after administration of the compound.
4. Mitochondrial Function & Insulin Sensitivity Enhanced oxygen consumption rates and improved glucose handling parameters have been documented in cellular and whole-animal metabolic assays.
5. Broader Metabolic Longevity Pathways Researchers are exploring how NNMT inhibition intersects with sirtuin activity, AMPK signaling, and other longevity-related cascades.

Research Strength Matrix & Comparison

Important Safety & Legal Information
5-Amino-1MQ is sold strictly for laboratory and scientific research use only. It has not undergone human clinical trials, is not approved for human consumption, and has not been evaluated by the FDA or any other regulatory agency for safety or efficacy in humans.
FOR RESEARCH USE ONLY • NOT FOR HUMAN CONSUMPTION Not evaluated by the FDA • For laboratory and scientific research purposes only.
Frequently Asked Questions (FAQ)

Q1: What is the primary molecular target of 5-Amino-1MQ? A: Nicotinamide N-Methyltransferase (NNMT).
Q2: How does 5-Amino-1MQ differ from NAD+ precursors like NMN or NR? A: It works upstream by preventing NAD+ consumption rather than providing more precursor material.
Why Researchers Choose 5-Amino-1MQ
- High membrane permeability
- Excellent selectivity profile
- Consistent effects across multiple tissue types in preclinical systems
- Active area of investigation in metabolic biochemistry and aging research
Ready to add to your cart for your lab? All products are third-party tested, shipped with COA, and supplied exclusively for research purposes.
Related Research Compounds: BPC-157 • TB-500 (Wolverine Stack) • 5-Amino-1MQ • Epitalon • etc.






Reviews
There are no reviews yet.